Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022

Upgrades

• For SolarEdge Technologies Inc SEDG, Northland Capital Markets upgraded the previous rating of Underperform to Market Perform. In the third quarter, SolarEdge Technologies showed an EPS of $0.91, compared to $1.45 from the year-ago quarter. At the moment, the stock has a 52-week-high of $375.90 and a 52-week-low of $190.15. SolarEdge Technologies closed at $211.30 at the end of the last trading period.
• According to Scotiabank, the prior rating for Delek US Holdings Inc DK was changed from Sector Underperform to Sector Perform. Delek US Hldgs earned $0.02 in the third quarter, compared to $0.13 in the year-ago quarter. The stock has a 52-week-high of $35.23 and a 52-week-low of $14.71. At the end of the last trading period, Delek US Hldgs closed at $33.62.
• According to William Blair, the prior rating for Stratasys Ltd SSYS was changed from Underperform to Market Perform. Stratasys earned $0.02 in the second quarter, compared to $0.02 in the year-ago quarter. At the moment, the stock has a 52-week-high of $28.00 and a 52-week-low of $12.69. Stratasys closed at $13.67 at the end of the last trading period.
• According to Goldman Sachs, the prior rating for Mettler-Toledo International Inc MTD was changed from Sell to Neutral. Mettler-Toledo Intl earned $10.18 in the third quarter, compared to $8.72 in the year-ago quarter. The current stock performance of Mettler-Toledo Intl shows a 52-week-high of $1699.11 and a 52-week-low of $1065.55. Moreover, at the end of the last trading period, the closing price was at $1298.71.
• Morgan Stanley upgraded the previous rating for Southern Copper Corp SCCO from Equal-Weight to Overweight. Southern Copper earned $0.56 in the second quarter, compared to $1.21 in the year-ago quarter. At the moment, the stock has a 52-week-high of $79.31 and a 52-week-low of $42.42. Southern Copper closed at $53.04 at the end of the last trading period.
• According to Deutsche Bank, the prior rating for Dave & Buster's Entertainment Inc PLAY was changed from Hold to Buy. For the second quarter, Dave & Buster's Enter had an EPS of $0.64, compared to year-ago quarter EPS of $1.07. The current stock performance of Dave & Buster's Enter shows a 52-week-high of $52.54 and a 52-week-low of $29.60. Moreover, at the end of the last trading period, the closing price was at $37.05.
• Piper Sandler upgraded the previous rating for 2U Inc TWOU from Underweight to Neutral. For the third quarter, 2U had an EPS of $0.05, compared to year-ago quarter EPS of $0.23. The stock has a 52-week-high of $20.98 and a 52-week-low of $4.70. At the end of the last trading period, 2U closed at $6.36.
• According to Macquarie, the prior rating for Block Inc SQ was changed from Neutral to Outperform. For the third quarter, Block had an EPS of $0.42, compared to year-ago quarter EPS of $0.37. At the moment, the stock has a 52-week-high of $165.20 and a 52-week-low of $51.34. Block closed at $62.67 at the end of the last trading period.
• For Viatris Inc VTRS, Piper Sandler upgraded the previous rating of Underweight to Neutral. Viatris earned $0.87 in the third quarter, compared to $0.99 in the year-ago quarter. At the moment, the stock has a 52-week-high of $15.60 and a 52-week-low of $8.42. Viatris closed at $10.97 at the end of the last trading period.
• According to Stifel, the prior rating for Global Partners LP GLP was changed from Hold to Buy. In the third quarter, Global Partners showed an EPS of $3.12, compared to $0.86 from the year-ago quarter. At the moment, the stock has a 52-week-high of $35.29 and a 52-week-low of $20.23. Global Partners closed at $29.96 at the end of the last trading period.
• According to Barclays, the prior rating for The Scotts Miracle Gro Co SMG was changed from Equal-Weight to Overweight. Scotts Miracle Gro earned $2.04 in the fourth quarter, compared to $0.82 in the year-ago quarter. At the moment, the stock has a 52-week-high of $167.09 and a 52-week-low of $39.05. Scotts Miracle Gro closed at $51.71 at the end of the last trading period.

See all analyst ratings upgrades.

Downgrades

• For Huntsman Corp HUN, Tudor Pickering downgraded the previous rating of Buy to Hold. Huntsman earned $0.71 in the third quarter, compared to $1.08 in the year-ago quarter. The current stock performance of Huntsman shows a 52-week-high of $41.65 and a 52-week-low of $23.54. Moreover, at the end of the last trading period, the closing price was at $26.72.
• Wolfe Research downgraded the previous rating for JELD-WEN Holding Inc JELD from Peer Perform to Underperform. JELD-WEN Holding earned $0.71 in the third quarter, compared to $0.45 in the year-ago quarter. The stock has a 52-week-high of $27.59 and a 52-week-low of $8.38. At the end of the last trading period, JELD-WEN Holding closed at $9.46.
• Truist Securities downgraded the previous rating for WM Technology Inc MAPS from Buy to Hold. WM Tech earned $0.06 in the third quarter, compared to $0.02 in the year-ago quarter. At the moment, the stock has a 52-week-high of $8.35 and a 52-week-low of $1.58. WM Tech closed at $1.93 at the end of the last trading period.
• For Marsh & McLennan Companies Inc MMC, Atlantic Equities downgraded the previous rating of Overweight to Neutral. In the third quarter, Marsh & McLennan showed an EPS of $1.18, compared to $1.08 from the year-ago quarter. The stock has a 52-week-high of $183.14 and a 52-week-low of $142.80. At the end of the last trading period, Marsh & McLennan closed at $163.01.
• According to Deutsche Bank, the prior rating for Adient PLC ADNT was changed from Buy to Hold. In the fourth quarter, Adient showed an EPS of $0.53, compared to $0.24 from the year-ago quarter. The stock has a 52-week-high of $50.96 and a 52-week-low of $27.15. At the end of the last trading period, Adient closed at $38.37.
• Chardan Capital downgraded the previous rating for Oyster Point Pharma Inc OYST from Buy to Neutral. In the second quarter, Oyster Point Pharma showed an EPS of $1.87, compared to $0.85 from the year-ago quarter. The current stock performance of Oyster Point Pharma shows a 52-week-high of $18.30 and a 52-week-low of $3.46. Moreover, at the end of the last trading period, the closing price was at $11.57.
• B of A Securities downgraded the previous rating for Ritchie Bros Auctioneers Inc RBA from Buy to Neutral. In the third quarter, Ritchie Bros Auctioneers showed an EPS of $0.53, compared to $0.45 from the year-ago quarter. The current stock performance of Ritchie Bros Auctioneers shows a 52-week-high of $72.73 and a 52-week-low of $48.65. Moreover, at the end of the last trading period, the closing price was at $51.29.
• For Ouster Inc OUST, Baird downgraded the previous rating of Outperform to Neutral. In the third quarter, Ouster showed an EPS of $0.20, compared to $0.08 from the year-ago quarter. At the moment, the stock has a 52-week-high of $5.54 and a 52-week-low of $0.76. Ouster closed at $1.21 at the end of the last trading period.
• Wedbush downgraded the previous rating for Williams-Sonoma Inc WSM from Outperform to Neutral. In the second quarter, Williams-Sonoma showed an EPS of $3.87, compared to $3.24 from the year-ago quarter. The current stock performance of Williams-Sonoma shows a 52-week-high of $176.89 and a 52-week-low of $101.58. Moreover, at the end of the last trading period, the closing price was at $123.47.
• According to Raymond James, the prior rating for ICU Medical Inc ICUI was changed from Outperform to Market Perform. In the third quarter, ICU Medical showed an EPS of $1.75, compared to $2.07 from the year-ago quarter. At the moment, the stock has a 52-week-high of $251.73 and a 52-week-low of $132.75. ICU Medical closed at $142.07 at the end of the last trading period.
• According to Deutsche Bank, the prior rating for Jack In The Box Inc JACK was changed from Buy to Hold. In the third quarter, Jack In The Box showed an EPS of $1.38, compared to $1.79 from the year-ago quarter. The stock has a 52-week-high of $96.87 and a 52-week-low of $54.80. At the end of the last trading period, Jack In The Box closed at $86.07.
• Piper Sandler downgraded the previous rating for Q2 Holdings Inc QTWO from Neutral to Underweight. Q2 Holdings earned $0.10 in the third quarter, compared to $0.03 in the year-ago quarter. The current stock performance of Q2 Holdings shows a 52-week-high of $81.56 and a 52-week-low of $25.53. Moreover, at the end of the last trading period, the closing price was at $26.44.
• For Benefitfocus Inc BNFT, Keybanc downgraded the previous rating of Overweight to Sector Weight. For the third quarter, Benefitfocus had an EPS of $0.12, compared to year-ago quarter EPS of $0.19. At the moment, the stock has a 52-week-high of $13.05 and a 52-week-low of $5.68. Benefitfocus closed at $10.40 at the end of the last trading period.
• According to Piper Sandler, the prior rating for Oyster Point Pharma Inc OYST was changed from Overweight to Neutral. For the second quarter, Oyster Point Pharma had an EPS of $1.87, compared to year-ago quarter EPS of $0.85. The stock has a 52-week-high of $18.30 and a 52-week-low of $3.46. At the end of the last trading period, Oyster Point Pharma closed at $11.57.
• For Q2 Holdings Inc QTWO, RBC Capital downgraded the previous rating of Outperform to Sector Perform. Q2 Holdings earned $0.10 in the third quarter, compared to $0.03 in the year-ago quarter. At the moment, the stock has a 52-week-high of $81.56 and a 52-week-low of $25.53. Q2 Holdings closed at $26.44 at the end of the last trading period.
• For Arcosa Inc ACA, Stephens & Co. downgraded the previous rating of Overweight to Equal-Weight. Arcosa earned $0.70 in the third quarter, compared to $0.57 in the year-ago quarter. The stock has a 52-week-high of $65.80 and a 52-week-low of $43.42. At the end of the last trading period, Arcosa closed at $59.32.
• According to Evercore ISI Group, the prior rating for Lyft Inc LYFT was changed from Outperform to In-Line. For the third quarter, Lyft had an EPS of $0.10, compared to year-ago quarter EPS of $0.05. The stock has a 52-week-high of $46.64 and a 52-week-low of $10.82. At the end of the last trading period, Lyft closed at $14.14.
• Jefferies downgraded the previous rating for Six Flags Entertainment Corp SIX from Buy to Hold. In the second quarter, Six Flags Entertainment showed an EPS of $0.68, compared to $0.81 from the year-ago quarter. The stock has a 52-week-high of $47.24 and a 52-week-low of $16.83. At the end of the last trading period, Six Flags Entertainment closed at $21.16.
• Jefferies downgraded the previous rating for IAA Inc IAA from Buy to Hold. IAA earned $0.45 in the third quarter, compared to $0.52 in the year-ago quarter. The current stock performance of IAA shows a 52-week-high of $51.12 and a 52-week-low of $31.32. Moreover, at the end of the last trading period, the closing price was at $38.42.

See all analyst ratings downgrades.

Initiations

• Deutsche Bank initiated coverage on Planet Labs PBC PL with a Buy rating. The price target for Planet Labs is set to $7.00. Planet Labs earned $0.15 in the second quarter, compared to $0.46 in the year-ago quarter. The current stock performance of Planet Labs shows a 52-week-high of $7.51 and a 52-week-low of $3.70. Moreover, at the end of the last trading period, the closing price was at $5.40.
• Deutsche Bank initiated coverage on BlackSky Technology Inc BKSY with a Buy rating. The price target for BlackSky Technology is set to $3.00. In the third quarter, BlackSky Technology showed an EPS of $0.11, compared to $0.67 from the year-ago quarter. The stock has a 52-week-high of $5.01 and a 52-week-low of $1.00. At the end of the last trading period, BlackSky Technology closed at $1.80.
• Raymond James initiated coverage on Kymera Therapeutics Inc KYMR with a Market Perform rating. For the third quarter, Kymera Therapeutics had an EPS of $0.79, compared to year-ago quarter EPS of $0.56. At the moment, the stock has a 52-week-high of $65.44 and a 52-week-low of $13.15. Kymera Therapeutics closed at $29.04 at the end of the last trading period.
• For ASML Holding NV ASML, Morgan Stanley initiated coverage, by setting the current rating at Overweight. In the third quarter, ASML Holding showed an EPS of $4.32, compared to $5.02 from the year-ago quarter. At the moment, the stock has a 52-week-high of $799.36 and a 52-week-low of $363.15. ASML Holding closed at $483.39 at the end of the last trading period.
• With a Buy rating, Canaccord Genuity initiated coverage on Passage Bio Inc PASG. The price target seems to have been set at $8.00 for Passage Bio. For the second quarter, Passage Bio had an EPS of $0.73, compared to year-ago quarter EPS of $0.90. The stock has a 52-week-high of $6.55 and a 52-week-low of $1.15. At the end of the last trading period, Passage Bio closed at $1.20.
• Canaccord Genuity initiated coverage on Rocket Pharmaceuticals Inc RCKT with a Buy rating. The price target for Rocket Pharmaceuticals is set to $53.00. In the third quarter, Rocket Pharmaceuticals showed an EPS of $0.87, compared to $0.79 from the year-ago quarter. The current stock performance of Rocket Pharmaceuticals shows a 52-week-high of $24.18 and a 52-week-low of $7.57. Moreover, at the end of the last trading period, the closing price was at $16.24.
• With a Buy rating, Canaccord Genuity initiated coverage on Generation Bio Co GBIO. The price target seems to have been set at $9.00 for Generation Bio. For the third quarter, Generation Bio had an EPS of $0.53, compared to year-ago quarter EPS of $0.56. At the moment, the stock has a 52-week-high of $9.59 and a 52-week-low of $3.96. Generation Bio closed at $6.47 at the end of the last trading period.
• Canaccord Genuity initiated coverage on Tenaya Therapeutics Inc TNYA with a Buy rating. The price target for Tenaya Therapeutics is set to $21.00. Tenaya Therapeutics earned $0.69 in the second quarter, compared to $13.26 in the year-ago quarter. The stock has a 52-week-high of $19.45 and a 52-week-low of $1.90. At the end of the last trading period, Tenaya Therapeutics closed at $1.92.
• JonesTrading initiated coverage on HCW Biologics Inc HCWB with a Buy rating. The price target for HCW Biologics is set to $8.00. HCW Biologics earned $0.11 in the third quarter, compared to $0.14 in the year-ago quarter. At the moment, the stock has a 52-week-high of $3.32 and a 52-week-low of $1.76. HCW Biologics closed at $2.28 at the end of the last trading period.
• With a Buy rating, Canaccord Genuity initiated coverage on Taysha Gene Therapies Inc TSHA. The price target seems to have been set at $16.00 for Taysha Gene Therapies. In the third quarter, Taysha Gene Therapies showed an EPS of $0.64, compared to $1.35 from the year-ago quarter. The current stock performance of Taysha Gene Therapies shows a 52-week-high of $12.17 and a 52-week-low of $1.35. Moreover, at the end of the last trading period, the closing price was at $2.00.

See all analyst ratings initiations.